Teva Pharmaceuticals is located across all major markets in Europe, operating across 28 manufacturing sites and employing over 19,000 people across its operations and commercial activities. We’re the leading generic drug company in Europe and our legacy in high-quality generics enables us to leverage our capabilities to bring forward complex generics and biosimilars at scale, to help create more value for patients and healthcare systems. We also have a strong innovative medicines portfolio focused on central nervous system disorders, respiratory diseases and oncology.

Through a global network of capabilities, we are discovering, developing and delivering our innovative, generic and biosimilar medicines to unlock more possibilities for patient care, positioning our business for greater opportunity and greater impact.